French medical aesthetics group Innerskin has successfully secured €12.8 million ($15 million) in a new funding round designed to fuel its ambitious European expansion. The investment was led by IRIS Ventures, a growth equity firm specializing in next-generation consumer brands, with continued participation from existing shareholder Label Capital. This significant capital injection is poised to accelerate the company's mission of transforming the skin health and modern aesthetics experience for consumers across the continent.
A New Standard in Aesthetic Wellness
Founded in 2022 by entrepreneur Chrystelle Eid, Innerskin has demonstrated remarkable growth by establishing 19 centers throughout France in just three years. The company has carved a niche by focusing on preventive face and body care, skillfully integrating high-performance technology with holistic, expert-led guidance. This unique approach is carefully tailored to meet the evolving needs of modern consumers who demand a premium, sophisticated, and results-driven customer experience.
At the core of Innerskin's strategy is a novel vision that seamlessly connects non-invasive clinical treatments with a proprietary medical-grade skincare line. This innovative model creates a fluid ecosystem that bridges the gap between clinical precision and an appealing, accessible lifestyle brand. By offering a comprehensive journey from in-clinic service to at-home care, the company effectively builds consumer trust, delivers tangible results, and fosters strong, lasting brand loyalty.
Strategic Partnership to Accelerate Growth
The €12.8 million investment provides Innerskin with the critical resources required to scale its operations and strategically enter new European markets. The partnership with IRIS Ventures is particularly significant, given the firm's deep expertise and proven track record in backing disruptive beauty and wellness brands. This collaboration signals strong market confidence in Innerskin's scalable business model and its leadership team's clear vision for the future of aesthetic care.
Chrystelle Eid, founder and CEO of Innerskin, described the investment as a pivotal moment that validates the company's progress and potential. She emphasized that partnering with IRIS Ventures brings not only capital but also invaluable category expertise and strategic support needed to lead the market. The funding will also fast-track the development of the company's mesocosmetics portfolio, further strengthening its unique position and comprehensive consumer offering.
Capitalizing on Evolving Consumer Demands
This funding round stands out within the broader European beauty and personal care landscape, where recent investments have often targeted B2B infrastructure or ingredient sustainability. In contrast, Innerskin’s model directly addresses the end-consumer by offering a holistic, service-and-product-based solution under a single trusted brand. This reflects a significant market shift toward investing in comprehensive, vertically integrated aesthetic wellness providers rather than just isolated enabling technologies or components.
Montse Suárez, founder of IRIS Ventures, praised Eid's exceptional vision and operational excellence, stating that Innerskin is setting a new industry standard for delivering sophistication at scale. Partner Celia Bosch added that the company uniquely merges premium beauty, medical-grade performance, and wellness, answering the modern consumer's call for transparent and integrated self-care. This combination directly addresses the growing demand for science-based experiences that deliver both efficacy and a sense of well-being.
With this significant capital infusion and the strategic backing of IRIS Ventures, Innerskin is powerfully positioned to redefine the medical aesthetics industry across Europe. The company's proven model of combining clinical expertise with a premium consumer brand addresses a clear and growing market gap for accessible, high-quality care. This next phase of growth will undoubtedly see Innerskin solidify its leadership position and make advanced, personalized skin health a new standard for consumers.